116 related articles for article (PubMed ID: 26722051)
21. Neoadjuvant chemotherapy, interval debulking surgery or primary surgery in ovarian carcinoma FIGO stage IV?
Tropé CG; Elstrand MB; Sandstad B; Davidson B; Oksefjell H
Eur J Cancer; 2012 Sep; 48(14):2146-54. PubMed ID: 22382201
[TBL] [Abstract][Full Text] [Related]
22. Primary peritoneal carcinoma and ovarian carcinoma - a ten-year comparative analysis.
Alka D; Abraham P; Ashish S; Anitha T; Vinotha T; Rachel CG; Ajit S
Klin Onkol; 2022; 35(1):63-71. PubMed ID: 35236083
[TBL] [Abstract][Full Text] [Related]
23. Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
Baratti D; Vaira M; Kusamura S; D'Amico S; Balestra MR; Cioppa T; Mingrone E; De Simone M; Deraco M
Eur J Surg Oncol; 2010 Nov; 36(11):1047-53. PubMed ID: 20832234
[TBL] [Abstract][Full Text] [Related]
24. Value of Diaphragmatic Surgery During Interval Debulking Surgery.
Pelissier A; Franke O; Darai E; Houvenaeghel G; Chereau E; Rouzier R
Anticancer Res; 2018 Jan; 38(1):411-416. PubMed ID: 29277802
[TBL] [Abstract][Full Text] [Related]
25. Lymphopenia after induction chemotherapy correlates with incomplete surgical resection in patients with advanced ovarian cancer.
Yoshino Y; Taguchi A; Takao M; Kashiyama T; Furusawa A; Uno M; Okada S; Kino N; Yasugi T
Int J Clin Oncol; 2019 Apr; 24(4):428-436. PubMed ID: 30506281
[TBL] [Abstract][Full Text] [Related]
26. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Jimenez W; Sardi A; Nieroda C; Sittig M; Milovanov V; Nunez M; Aydin N; Gushchin V
Ann Surg Oncol; 2014 Dec; 21(13):4218-25. PubMed ID: 24986239
[TBL] [Abstract][Full Text] [Related]
27. Prognosis for advanced-stage primary peritoneal serous papillary carcinoma and serous ovarian cancer in Taiwan.
Chao KC; Chen YJ; Juang CM; Lau HY; Wen KC; Sung PL; Fang FY; Twu NF; Yen MS
Taiwan J Obstet Gynecol; 2013 Mar; 52(1):81-4. PubMed ID: 23548224
[TBL] [Abstract][Full Text] [Related]
28. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
29. Primary debulking surgery versus neo-adjuvant chemotherapy in stage III/IV ovarian cancer: Comparison of perioperative morbidity and survival data in Pakistani women.
Chishti U; Aziz AB
J Pak Med Assoc; 2015 Mar; 65(3):306-9. PubMed ID: 25933567
[TBL] [Abstract][Full Text] [Related]
30. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.
Cashin PH; Graf W; Nygren P; Mahteme H
Eur J Surg Oncol; 2012 Jun; 38(6):509-15. PubMed ID: 22475555
[TBL] [Abstract][Full Text] [Related]
31. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Oliva GD; Laterza B; Deraco M
Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150
[TBL] [Abstract][Full Text] [Related]
32. Multicenter Clinicopathological Study of High-Grade Serous Carcinoma Presenting as Primary Peritoneal Carcinoma.
Komiyama S; Nishijima Y; Kondo H; Nomura H; Yamaguchi S; Futagami M; Arai H; Yokoyama Y; Suzuki N; Mikami M; Kubushiro K; Aoki D; Udagawa Y; Nishimura R
Int J Gynecol Cancer; 2018 May; 28(4):657-665. PubMed ID: 29324533
[TBL] [Abstract][Full Text] [Related]
33. Radical surgery versus standard surgery for primary cytoreduction of bulky stage IIIC and IV ovarian cancer: an observational study.
Ren Y; Jiang R; Yin S; You C; Liu D; Cheng X; Tang J; Zang R
BMC Cancer; 2015 Aug; 15():583. PubMed ID: 26268818
[TBL] [Abstract][Full Text] [Related]
34. Interval debulking surgery in patients with Federation of Gynecology and Obstetrics (FIGO) stage IIIC and IV ovarian cancer.
Keyver-Paik MD; Zivanovic O; Rudlowski C; Höller T; Wolfgarten M; Kübler K; Schröder L; Mallmann MR; Pölcher M; Kuhn W
Onkologie; 2013; 36(6):324-32. PubMed ID: 23774146
[TBL] [Abstract][Full Text] [Related]
35. Timing and pattern of recurrence in ovarian cancer patients with high tumor dissemination treated with primary debulking surgery versus neoadjuvant chemotherapy.
Petrillo M; Ferrandina G; Fagotti A; Vizzielli G; Margariti PA; Pedone AL; Nero C; Fanfani F; Scambia G
Ann Surg Oncol; 2013 Nov; 20(12):3955-60. PubMed ID: 23838915
[TBL] [Abstract][Full Text] [Related]
36. Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Robella M; Vaira M; Marsanic P; Mellano A; Borsano A; Cinquegrana A; Sottile A; De Simone M
Minerva Chir; 2014 Feb; 69(1):27-35. PubMed ID: 24675244
[TBL] [Abstract][Full Text] [Related]
37. Optimal timing of interval debulking surgery in advanced ovarian cancer: yet to be defined?
Stoeckle E; Boubli B; Floquet A; Brouste V; Sire M; Croce S; Thomas L; Guyon F
Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):407-12. PubMed ID: 21835539
[TBL] [Abstract][Full Text] [Related]
38. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
[TBL] [Abstract][Full Text] [Related]
39. Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy.
Esselen KM; Rodriguez N; Growdon W; Krasner C; Horowitz NS; Campos S
Gynecol Oncol; 2012 Oct; 127(1):51-4. PubMed ID: 22659193
[TBL] [Abstract][Full Text] [Related]
40. Peritoneal metastases from small bowel cancer: Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in The Netherlands.
van Oudheusden TR; Lemmens VE; Braam HJ; van Ramshorst B; Meijerink J; te Velde EA; Mehta AM; Verwaal VJ; de Hingh IH
Surgery; 2015 Jun; 157(6):1023-7. PubMed ID: 25818658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
